Correlation Between ZyVersa Therapeutics and CytomX Therapeutics
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and CytomX Therapeutics, you can compare the effects of market volatilities on ZyVersa Therapeutics and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and CytomX Therapeutics.
Diversification Opportunities for ZyVersa Therapeutics and CytomX Therapeutics
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between ZyVersa and CytomX is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and CytomX Therapeutics go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and CytomX Therapeutics
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the CytomX Therapeutics. In addition to that, ZyVersa Therapeutics is 1.1 times more volatile than CytomX Therapeutics. It trades about -0.07 of its total potential returns per unit of risk. CytomX Therapeutics is currently generating about 0.02 per unit of volatility. If you would invest 164.00 in CytomX Therapeutics on August 27, 2024 and sell it today you would lose (75.00) from holding CytomX Therapeutics or give up 45.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. CytomX Therapeutics
Performance |
| Timeline |
| ZyVersa Therapeutics |
| CytomX Therapeutics |
ZyVersa Therapeutics and CytomX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and CytomX Therapeutics
The main advantage of trading using opposite ZyVersa Therapeutics and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| CytomX Therapeutics vs. Eliem Therapeutics | CytomX Therapeutics vs. HCW Biologics | CytomX Therapeutics vs. Scpharmaceuticals | CytomX Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |